Medical technology company Hologic, headquartered in Marlborough, announced Wednesday it has acquired Acessa Health Inc. for approximately $80 million in cash plus contingent payments based on future revenue growth.
Acessa Health is a privately-held company specializing in minimally invasive treatment for uterine fibroids. The company markets the Acessa ProVu system. Clinical studies have shown the system is a safe and minimally invasive alternative to hysterectomy and myomectomy, according to Hologic.
Acessa Health is based in Austin, Texas, and employs approximately 35 people.
Hologic estimates Acessa Health will generate approximately $13 million of revenue in fiscal 2021. The acquisition is expected to be slightly dilutive to Hologic’s non-GAAP earnings per share in fiscal 2021, break even in 2022, and accretive thereafter.
